- Letter from the Editor
- Lessons learned or business as usual?
- David Große Kathöfer
- Commentary
- Mergers & acquisitions (M&A) in the pharmaceutical industry: the wheel keeps on turning
- Matthias Hornke and Sven Mandewirth
- Research Paper
- New biocide active substances: needs and challenges in the EU as viewed by industry
- Elina Kähkönen, Teemu Hirvonen and Katrina Nordström
- Practitioner’s Section
- REACH implementation costs in the Belgian food industry: a semi-qualitative study
- Genserik Reniers, Hanne Geelen, Emilie Goris and Amaryllis Audenaert
- Performance improvement in pharmaceutical R&D through new outsourcing models
- Gunter Festel, Alexander Schicker and Roman Boutellier
- Sustainability in the chemical and pharmaceutical industry - results of a benchmark analysis
- Jürgen Peukert and Karin Sahr
